Mean weight loss for digitally engaged patients, vs 17.6% with medication alone.
22.9%
Mean weight loss
Digital engagement amplifies outcomes
Digital support changes what GLP-1 medication can achieve.
Reaching the people other services miss
Community-led delivery changes who engages, and who succeeds.
Psychology drives sustained outcomes
Psychological wraparound converts medication response into lasting change.
Outcomes across comorbidity and complex need
Those at highest risk are the most likely to engage.
References
Johnson H, Clift AK, Reisel D, Huang DR. Digital engagement significantly enhances weight loss outcomes in adults with obesity treated with tirzepatide (n=126,553). JMIR preprint, accepted. https://pmc.ncbi.nlm.nih.gov/articles/PMC12856402/
Johnson H, Clift AK, Reisel D, Huang DR. Digital engagement enhances weight loss outcomes with tirzepatide: cohort study of 66,846 adults. Obesity Week 2025 Poster-446. Listed at https://obesityweek.org/wp-content/uploads/2023/04/OW25-Posters-by-Number-as-of-10-30-2025.pdf — internal source: poster_446_OW_Tirz_Johnson_1.pdf
Johnson H, Clift AK, Reisel D, Huang DR. Digital engagement enhances weight loss outcomes in adults treated with GLP-1 receptor agonists. J Med Internet Res 2025; 27: e69466. https://www.jmir.org/2025/1/e69466